- Illustrations
- Specialized Illustrations
- Cellular and molecular processes
- Detailed Blood Cells Forming a Blood Clot
Detailed Blood Cells Forming a Blood Clot
Close-up view of diverse blood cells entangled within a developing blood clot.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Interlaced fibrin strands form a pale, filamentous mesh that spans the field and entraps erythrocytes (red blood cells) with their characteristic biconcave discoid profile. Platelets appear as irregular, stellate aggregates adherent to the fibrin scaffold, occupying the spaces between clustered erythrocytes and bridging adjacent fibrin fibers. The resulting thrombus architecture reads as a mixed cellular plug, with platelet-rich microdomains embedded within a denser red cell mass. Scale and depth cues support a luminal, intravascular context rather than a surface smear. Clinically, this microanatomy explains why thrombi behave differently depending on flow conditions. Platelet-dominant thrombus formation under high shear, as in arterial circulation over a ruptured atherosclerotic plaque, underpins the logic of antiplatelet therapy in acute coronary syndrome, while fibrin and red cell rich thrombi that develop with venous stasis correlate with deep vein thrombosis and the embolic risk of pulmonary embolism. Dense fibrin networks also limit endogenous fibrinolysis, a point that matters when discussing timing and efficacy of thrombolytic agents. Small details, big consequences. Use this illustration for lectures on hemostasis and thrombosis in medical, nursing, and biomedical science curricula, and for textbook figures distinguishing platelet plug formation from fibrin-stabilized coagulation. It also fits clinical education materials on thrombus versus embolus, anticoagulants versus antiplatelet drugs, and the pathophysiology behind DVT, ischemic stroke, and myocardial infarction. Anatomical accuracy verified by SciePro's Medical Advisory Board.